Outcomes study will assess mortality and hospitalization in patients treated with Vafseo compared to current standard of care "We look forward to begin treating CKD anemia patients on dialysis with ...
Hansa Biopharma, "Hansa" and Genethon, a pioneer and a leader in gene therapy research and development for rare genetic diseases, today announced initiation of GNT-018-IDES, a Phase 2 trial in ...
The BiliLux phototherapy light has its irradiance peaks in the most effective wavelength range to reduce the bilirubin which is 460-490 nm. By achieving extremely high irradiance levels ...